Rekombinanter CD8 Antikörper
-
- Target Alle CD8 Antikörper anzeigen
- CD8
- Antikörpertyp
- Recombinant Antibody
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD8 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB), ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- Affinity-chromatography
- Immunogen
- A synthesized peptide derived from human CD80
- Klon
- 3C3
- Isotyp
- IgG
- Top Product
- Discover our top product CD8 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200, IP:1:200-1:1000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CD8
- Andere Bezeichnung
- CD8 (CD8 Produkte)
- Synonyme
- CD8 antikoerper, Leu2 antikoerper, MAL antikoerper, p32 antikoerper, CD8a molecule antikoerper, CD8A antikoerper
- Hintergrund
-
Background: Involved in the costimulatory signal essential for T-lymphocyte activation. T-cell proliferation and cytokine production is induced by the binding of CD28, binding to CTLA-4 has opposite effects and inhibits T-cell activation.
Aliases: T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80), CD80, CD28LG CD28LG1 LAB7
- UniProt
- P33681
-